Cardinal Health (NYSE:CAH) Price Target Cut to $128.00 by Analysts at Robert W. Baird

Cardinal Health (NYSE:CAH - Get Free Report) had its target price reduced by equities research analysts at Robert W. Baird from $134.00 to $128.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Robert W. Baird's price objective points to a potential upside of 29.42% from the stock's current price.

A number of other research firms also recently issued reports on CAH. Wells Fargo & Company dropped their price target on Cardinal Health from $96.00 to $94.00 and set an "underweight" rating on the stock in a research note on Monday. StockNews.com upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Thursday. Argus upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating in a research note on Friday, February 9th. UBS Group upped their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a report on Monday, February 5th. Finally, SVB Leerink initiated coverage on shares of Cardinal Health in a report on Monday, February 26th. They issued an "outperform" rating and a $125.00 target price for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $105.79.

Cardinal Health Stock Down 4.0 %

NYSE CAH traded down $4.08 on Friday, hitting $98.90. 3,445,729 shares of the stock were exchanged, compared to its average volume of 2,288,769. The company has a 50-day moving average price of $109.28 and a 200-day moving average price of $104.97. The company has a market cap of $24.06 billion, a PE ratio of 38.94, a PEG ratio of 1.03 and a beta of 0.71. Cardinal Health has a fifty-two week low of $77.56 and a fifty-two week high of $116.04.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.13. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The business had revenue of $54.90 billion during the quarter, compared to the consensus estimate of $56.05 billion. During the same quarter in the previous year, the firm earned $1.74 EPS. The company's revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts predict that Cardinal Health will post 7.28 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CAH. Mediolanum International Funds Ltd acquired a new position in shares of Cardinal Health in the 1st quarter valued at about $3,573,000. Larson Financial Group LLC boosted its holdings in shares of Cardinal Health by 98.3% in the 1st quarter. Larson Financial Group LLC now owns 3,828 shares of the company's stock valued at $428,000 after buying an additional 1,898 shares during the period. Rehmann Capital Advisory Group boosted its holdings in shares of Cardinal Health by 12.2% in the 1st quarter. Rehmann Capital Advisory Group now owns 2,833 shares of the company's stock valued at $317,000 after buying an additional 307 shares during the period. BI Asset Management Fondsmaeglerselskab A S boosted its holdings in shares of Cardinal Health by 238.6% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 9,783 shares of the company's stock valued at $1,095,000 after buying an additional 6,894 shares during the period. Finally, Patron Partners LLC acquired a new position in shares of Cardinal Health in the 1st quarter valued at about $213,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.